Global University Venturing

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Ten University of California startups are hoping to open 2021 with a bang by securing one of two $50,000 prizes at the GCV Digital Forum next month.

Tokyo University of Science helped extend Gojo & Company's series D round to $68.6m, lifting the microfinancing provider's overall funding to around $142m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The UBC-linked antibody drug developer has added $73m to its initial public offering, and its shares are still trading at more than double the IPO price.

Stanford-StartX Fund is set to exit payment processing technology provider Poynt in an acquisition sized at up to $365m.

University of Florida has backed a second round for Atsena, a vision loss therapy developer exploiting inventions the institution had originally licensed to Sanofi.

Junshi Biosciences has invested in the University of Birmingham-founded cancer immunotherapy developer, building on a research collaboration deal.

The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Fudan University’s Furong Investment has co-led a round for Singlera Genomics, which will use the cash to advance its pipeline of cancer screening products.